| Ytd | 78.86% | |
| 1y | 66.16% |
| Open | 10.19 | Prev Close | 10.05 | Low | 10.19 | High | 11.16 | Mkt Cap | 99.51M |
| Vol | 56.12K | Avg Vol | 29.82K | EPS | -0.07 | P/E | N/A | Forward P/E | -42.82 |
| Beta | 0.57 | Short Ratio | 0.23 | Inst. Own | 14.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 9.32 | 200-d Avg | 6.99 | 1yr Est | 14.00 |
ICCC News
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.21 per share. This is a 31.25 percent incre
On May 8, 2026, ImmuCell Corporation and Norbrook Laboratories Limited (incorporated and registered
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.31) per share. This is a 616.67 percent decr
ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health c
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell"), an animal health company that develops, ma
Animal health company ImmuCell receives an Incomplete Letter from the FDA for its Re-Tain NADA. Comp
In seeking FDA approval to bring its innovative Re-Tain® product to market, ImmuCell received Comple
ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell"), an animal health company that develops, man
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.02) per share. This is a 77.78 percent incre
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCe
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.06 per share. This is a 130 percent increas
- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing anima
ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.06 per share. This is a 140 percent increas
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal
Preliminary, Unaudited Total Sales Results: 20242023$ Increase% Increase During the Three-Month Peri
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.09) per share. This is a 25 percent increase
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.12) per share. This is a 50 percent decrease
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.18) per share. This is a 100 percent decreas
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market tr
With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that m
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal
On Friday, 199 companies reached new 52-week lows.
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.30) per share. This is a 528.57 percent decr
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Thursday's session saw 337 companies set new 52-week lows.
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.21) per share. This is a 2200 percent decrea